AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
The Rise of Simeglotide: From Diabetes Treatment to Weight Loss Solution
Exploring the journey of Simeglotide's development by Novo Nordisk, this chapter uncovers the shift in focus from treating diabetes to unintentionally becoming a popular weight loss option. The episode discusses the challenges and opportunities faced by Novo Nordisk as they navigate the unexpected demand for their drug, Ozempic, for weight management purposes. It sheds light on the evolving landscape of pharmaceutical marketing and the complex interplay between medication usage, patient needs, and company strategies.